# Eli Lilly and Company (LLY): SI in SEC Filings | SI Exposure > Eli Lilly and Company (LLY): 72.7% of its 10-K, 10-Q and 8-K filings in the last four quarters say "artificial intelligence". No "super intelligence" yet. Source: https://tsio.si/exposure/lly/ Updated: 2026-11-11 Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex 1. [Home](https://tsio.si/) 2. [SI Exposure](https://tsio.si/exposure/) 3. Eli Lilly and Company (LLY) SI Exposure · Rank 5 of 100 · Health Care # Eli Lilly and Company (LLY) and SI **8 of Eli Lilly and Company's 11 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 72.7%, rank 5 of the 100 largest US companies.** It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026. Updated **Nov 11, 2026** · SEC CIK [59478](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478) · Sector **Health Care** By quarter [The full ranking](https://tsio.si/exposure/#ranking) [Share on X](https://x.com/intent/post?text=Eli+Lilly+and+Company+and+SI%3A+72.7%25+of+its+10-K%2C+10-Q+and+8-K+filings+now+contain+the+phrase%2C+rank+5+of+100.+From+SEC+EDGAR%3A&url=https%3A%2F%2Ftsio.si%2Fexposure%2Flly%2F) - **Share, last 4 quarters**: 72.7% - **Filings with the phrase**: 8 - **New name, all time**: 0 - **Rank of 100**: 5 Over time ## Eli Lilly and Company filings, quarter by quarter Since Q1 2023: how many 10-K, 10-Q and 8-K filings Eli Lilly and Company made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence". *Chart: Share of Eli Lilly and Company 10-K, 10-Q and 8-K filings that contain either name. Per calendar quarter; Q4 2026 runs to Nov 11, 2026.* | Quarter | Filings | Old name | New name | Share | |---|---|---|---|---| | Q4 2026 | 2 | 2 | 0 | 100.0% | | Q3 2026 | 2 | 2 | 0 | 100.0% | | Q2 2026 | 4 | 2 | 0 | 50.0% | | Q1 2026 | 2 | 2 | 0 | 100.0% | | Q4 2025 | 3 | 2 | 0 | 66.7% | | Q3 2025 | 3 | 2 | 0 | 66.7% | | Q2 2025 | 3 | 2 | 0 | 66.7% | | Q1 2025 | 4 | 3 | 0 | 75.0% | | Q4 2024 | 3 | 2 | 0 | 66.7% | | Q3 2024 | 6 | 2 | 0 | 33.3% | | Q2 2024 | 4 | 2 | 0 | 50.0% | | Q1 2024 | 3 | 2 | 0 | 66.7% | | Q4 2023 | 2 | 0 | 0 | 0.0% | | Q3 2023 | 2 | 0 | 0 | 0.0% | | Q2 2023 | 3 | 0 | 0 | 0.0% | | Q1 2023 | 4 | 0 | 0 | 0.0% | 10-K, 10-Q and 8-K filings by calendar quarter. Old name: filings with "artificial intelligence". New name: filings with "super intelligence" or "superintelligence". A filing with both counts once in the share. ## Filings with the new name None yet. When Eli Lilly and Company first files a document with "super intelligence" or "superintelligence", it appears here with a link. ## Latest filings with "artificial intelligence" 1. Oct 29, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947826000104/q326lillysalesandearningsp.htm) 0000059478-26-000104 2. Oct 29, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/lly-20260930.htm) 0000059478-26-000108 3. Aug 5, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947826000077/q226lillysalesandearningsp.htm) 0000059478-26-000077 4. Aug 5, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm) 0000059478-26-000081 5. Apr 30, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947826000043/q126lillysalesandearningsp.htm) 0000059478-26-000043 6. Apr 30, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/lly-20260331.htm) 0000059478-26-000045 7. Feb 12, 2026 [10-K](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm) 0000059478-26-000013 8. Feb 4, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947826000008/q425lillysalesandearningsp.htm) 0000059478-26-000008 9. Oct 30, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947825000251/q325lillysalesandearningsp.htm) 0000059478-25-000251 10. Oct 30, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/lly-20250930.htm) 0000059478-25-000254 11. Aug 7, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/59478/000005947825000202/q225lillysalesandearningsp.htm) 0000059478-25-000202 12. Aug 7, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/59478/000005947825000204/lly-20250630.htm) 0000059478-25-000204 Embed ## Put this card on any page A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0. Copy the embed ``` SI Exposure of Eli Lilly and Company: 72.7% of its 10-K, 10-Q and 8-K filings contain "artificial intelligence" ``` ![SI Exposure card for Eli Lilly and Company](https://tsio.si/exposure/lly/card.svg) Compare ## Neighbors in the ranking and sector peers [Rank 3 · Telecommunications**Arista Networks Inc.**88.9% of filings · 0 with the new name](https://tsio.si/exposure/anet/) [Rank 4 · Finance**S&P Global Inc.**81.8% of filings · 0 with the new name](https://tsio.si/exposure/spgi/) [Rank 6 · Technology**KLA Corporation**71.4% of filings · 0 with the new name](https://tsio.si/exposure/klac/) [Rank 7 · Health Care**Pfizer Inc.**71.4% of filings · 0 with the new name](https://tsio.si/exposure/pfe/) [Rank 13 · Health Care**Altria Group Inc.**61.5% of filings · 0 with the new name](https://tsio.si/exposure/mo/) [Rank 34 · Health Care**Gilead Sciences Inc.**35.7% of filings · 0 with the new name](https://tsio.si/exposure/gild/)